Northern blot analysis of maspin in cancer cell lines and human tissues. Northern blot analysis of maspin in cancer cell lines and human tissues. A, HMECs.

Slides:



Advertisements
Similar presentations
VALERIE H. CHEN Transforming Growth Factor (TGF) Beta Receptor 2 and Gastric Cancer.
Advertisements

EHT, a New Member of the MTG8/ETO Gene Family, Maps on 20q11 Region and Is Deleted in Acute Myeloid Leukemias by Nicola Stefano Fracchiolla, Gualtiero.
IL-1β stimulates CXCL5 and CXCL8 gene expression and protein secretion in A549 cells in a time- and dose-dependent manner. IL-1β stimulates CXCL5 and CXCL8.
سرطان الثدي Breast Cancer
Expression of Hoxa9 and Meis1a in spleen cells isolated from leukemic recipients of Hoxa9‐ and Meis1a‐transduced bone marrow cells. Expression of Hoxa9.
25(OH)D and 1,25(OH)2D perfusion treatment effect on cancer-related markers: IF stains illustrating expression levels for Ki-67 (A), cyclin D1 (B), ErbB-2.
Proline supplementation during P5CS protein knockdown suppressed GCN2 activation. Proline supplementation during P5CS protein knockdown suppressed GCN2.
High-throughput analysis of informative CpG sites for the four studied tumor suppressor genes (A-D). High-throughput analysis of informative CpG sites.
by T. G. Willis, I. R. Zalcberg, L. J. A. Coignet, I. Wlodarska, M
Volume 115, Issue 4, Pages (October 1998)
Volume 117, Issue 5, Pages (November 1999)
Retroviral vector–mediated transfer and expression of human tissue plasminogen activator gene in human endothelial and vascular smooth muscle cells  Daryoush.
Overexpression of BTAK/Aurora-A in ovarian carcinoma.
SIRT1 is downregulated in human gastric cancer (GC).
Knockdown of endogenous WT-hTER by a short hairpin RNA (siRNA) directed specifically against the human WT telomerase RNA template. Knockdown of endogenous.
Expression of multiple forms of MEL1 gene products.
A: Gene expression of β-myosin heavy chain (hypertrophic marker) was analyzed on real-time PCR and normalized against 18S expression. n = 8–11 for each.
Three period Homologs in Mammals: Differential Light Responses in the Suprachiasmatic Circadian Clock and Oscillating Transcripts Outside of Brain  Mark.
Quantification of NMT knockdown.
Aberrant regulation of HDAC2 and its association with malignant proliferation of human gastric cancer. Aberrant regulation of HDAC2 and its association.
TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor tissues. TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor.
Methylation status of IGFBPL1 in human breast cancer.
Representative Western blot analyses of S-phase and other proteins from PC3 cell lysates obtained 3 days after oligomer (400 nm)/Lipofectin (15 μg/ml)
BORIS mRNA expression in DNMT deficient HCT116 cell lines.
FAK overexpression in invasive human breast cancer and DCIS
BME treatment increases granzyme B expression in NK 3.3 cells.
Protein expression profile in a dasatinib-resistant cell line.
Colony-forming capacity of CD34+ cells with and without CLL-1 expression. Colony-forming capacity of CD34+ cells with and without CLL-1 expression. CD34+
Imatinib mesylate inhibits PDGF-mediated ERK and Akt activation.
ALDH1A3 is mainly responsible for the ALDH activity in two human cholangiocarcinoma lines. ALDH1A3 is mainly responsible for the ALDH activity in two human.
CNDT2.5 cells express mRNA for synaptophysin and neuron-specific enolase. CNDT2.5 cells express mRNA for synaptophysin and neuron-specific enolase. RT-PCR.
Effect of nicotinamide and carbogen on 5-FU uptake (measured as SUV3
Effect of expressing an activated mutant (Rac V12) and an inactivated mutant (Rac N17) of Rac on PTHRP gene expression levels and on JNK activation. Effect.
Effect of other nucleoside analogues on p38 MAPK phosphorylation levels. Effect of other nucleoside analogues on p38 MAPK phosphorylation levels. A, MM.1S.
VEGF expression in neoplastic and normal prostate tissue.
A, one-step viral growth curves: RT treatment increased the virus yield in MV-CEA–treated U87 cells by up to 2 log as compared with MV-CEA infection only.
MiR-200c is a PI3K–AKT signaling pathway regulator in CRC
Expression of CRC stem cell markers and L1 in CRC cells.
Effect of UV irradiation on PTHRP gene expression.
sir2α null cells differentiate in vitro.
A, RT-PCR expression of matriptase-1 and matriptase-2 in a variety of 24 human cell lines. A, RT-PCR expression of matriptase-1 and matriptase-2 in a variety.
SAF-1 expression in clinical breast cancer tissues.
Specific up-regulation and down-regulation of immunomodulatory genes in human breast and colorectal cancers. Specific up-regulation and down-regulation.
IGF-IR in human head and neck cancer.
Expression pattern of TLR-4 and MyD88 in EOC cells.
Expression of S100A11 in bulk pancreatic tissues (pancreatic cancer, n = 22; IPMN, n = 18; nonneoplastic pancreas, n = 22). Expression of S100A11 in bulk.
DNA demethylation reactivates GSN expression in gastric cancer cells.
PKCζ is tyrosine phosphorylated by EGF and contributes to EGF-induced activation of ERK in Mef cells. PKCζ is tyrosine phosphorylated by EGF and contributes.
Nested RT-PCR of Mammaglobin and CK19 mRNA in plasma and circulating cells of controls (C) and patients (T) with breast cancer. Nested RT-PCR of Mammaglobin.
SBC-5 miR-335+, but not SBC-5 miR-29a+, exhibited reduced IGF-IR expression. SBC-5 miR-335+, but not SBC-5 miR-29a+, exhibited reduced IGF-IR expression.
Establishment of MajSAT RNA–expressing mice.
Reduced klotho expression in pancreatic cancer.
Correlations of the breast cancer hypoxia metagene with Ki67 and the proliferation metagene. Correlations of the breast cancer hypoxia metagene with Ki67.
Characterization of DNA-PK and PARP-1 levels and activities in the cell lines studied. Characterization of DNA-PK and PARP-1 levels and activities in the.
Met is expressed in Her2-overexpressing cell lines and Her2 (+) breast tumors. Met is expressed in Her2-overexpressing cell lines and Her2 (+) breast tumors.
Osteoactivin is overexpressed in aggressively bone metastatic 4T1 subpopulations versus weakly bone metastatic breast cancer populations. Osteoactivin.
ODC protein expression in paired benign and cancer tissue obtained from patients with PCA. The protein expression was measured by immunoblot analysis in.
Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Expression.
ROC analysis of MIC-1 and CA19-9.
Western blot analysis for bFGF expression in human glioma cell lines.
Expression of HIF-1α and β-catenin in hypoxic HCC cell lines and HAL-treated xenografts. Expression of HIF-1α and β-catenin in hypoxic HCC cell lines and.
Immunoblot analysis in PANC1 and MSTO-211H cells.
Expression data from genes involved in regulation of transit through the cell cycle in response to treatment with E2 and OHT. A. Expression data from genes.
A, LOH on chromosome 17q (D17S785; expected size, 181–207 bp) in SC-IDC (Lane 2), SC-DCIS (Lane 3), clear-cut normal epithelial cells (Lane 4), DCIS (Lane.
Impact of IFNγ in B16 melanoma metastasis.
Detection of E-cadherin fragments in human prostate cancer metastases.
T-cell expression of second-generation CARs
Effect of dexamethasone on PCDGF/GP88 mRNA and protein expressions and effect of PCDGF/GP88 on dexamethasone-induced cell death. Effect of dexamethasone.
Expression of chemokine receptors in A-498 cell line.
Cells expressing mutant NADK-I90F exhibit low ROS and elevated NADP and NADPH levels. Cells expressing mutant NADK-I90F exhibit low ROS and elevated NADP.
Presentation transcript:

Northern blot analysis of maspin in cancer cell lines and human tissues. Northern blot analysis of maspin in cancer cell lines and human tissues. A, HMECs and seven human breast cancer cell lines. B, nine pancreatic cancer cell lines. C, six gastric cancer cell lines. D, four melanoma cell lines. Each lane contains 10 μg of total RNA. E, expression of maspin in normal tissues. The blot containing 2 μg poly(A) RNA per lane was purchased from Clontech. The blots were hybridized with 2.5 kb maspin cDNA probe. 36B4 was used as loading and transfer control. Nicolai Maass et al. Clin Cancer Res 2001;7:812-817 ©2001 by American Association for Cancer Research